Cargando…
The role of procalcitonin in acute heart failure patients
Acute dyspnoea is a common chief complaint in the emergency department and is mainly caused by cardiac and pulmonary underlying diagnoses. In patients with acute heart failure (AHF), an early initiation of adequate therapy is important to improve patient outcome. Clinical differentiation of pulmonar...
Autores principales: | Möckel, Martin, Searle, Julia, Maisel, Alan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542739/ https://www.ncbi.nlm.nih.gov/pubmed/28772049 http://dx.doi.org/10.1002/ehf2.12189 |
Ejemplares similares
-
Acute heart failure facts and numbers: acute heart failure populations
por: Searle, Julia, et al.
Publicado: (2016) -
Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference?
por: Möckel, Martin, et al.
Publicado: (2018) -
Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial
por: Maisel, Alan, et al.
Publicado: (2012) -
Cardiorenal biomarkers in acute heart failure
por: Choudhary, Rajiv, et al.
Publicado: (2012) -
Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs
por: Teichman, Sam L., et al.
Publicado: (2015)